ES2064156T3 - Derivados de 3-sulfonil-amino-2-(1h)-quinoleinona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Derivados de 3-sulfonil-amino-2-(1h)-quinoleinona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2064156T3
ES2064156T3 ES92403014T ES92403014T ES2064156T3 ES 2064156 T3 ES2064156 T3 ES 2064156T3 ES 92403014 T ES92403014 T ES 92403014T ES 92403014 T ES92403014 T ES 92403014T ES 2064156 T3 ES2064156 T3 ES 2064156T3
Authority
ES
Spain
Prior art keywords
branched
linear
amino
trihalomethyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92403014T
Other languages
English (en)
Inventor
Alex Cordi
Patrice Desos
Jean Lepagnol
John Randle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2064156T3 publication Critical patent/ES2064156T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA (I): EN LA QUE: X,Y,Z DIFERENTES, REPRESENTAN UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN GRUPO NITRO, CIANO, ACIDO, TRIHALOGENOMETILO, ALQUILO (C1-C6) LINEAL O RAMIFICADO, ALKOXI (C1-C6) LINEAL O RAMIFICADO, AMINO (SUSTITUIDO O NO POR UN GRUPO ACIL (C1-C6) LINEAL O RAMIFICADO), ES ADYACENTES, FORMAN CON LOS ATOMOS DE CARBONO A LOS QUE UNIDOS, UN CICLO FENILO O UN HETEROCICLO DE 5 O 6 ESLABONES QUE COMPRENDEN DE 1 A 3 HETEROATOMOS, PREFERENTEMENTE UN CICLO 1,2,5-OXADIAZOL, R REPRESENTA UN GRUPO ALQUILO (C1-C6) LINEAL O RAMIFICADO, TRIHALOGENOMETILO, FENILO (SUSTITUIDO O NO POR UNO O VARIOS ATOMOS DE HALOGENO O GRUPO ALQUILO (C1-C6) LINEAL O RAMIFICADO, TRIHALOGENOMETILO, ALKOXI (C1-C6) LINEAL O RAMIFICADO), 2-TIENILO (SUSTITUIDO O NO POR UN ATOMO DE HALOGENO), NAFTILO O ESTIRILO, A REPRESENTA UN RADICAL CH O UN ATOMO DE NITROGENO. MEDICAMENTOS.
ES92403014T 1991-11-14 1992-11-09 Derivados de 3-sulfonil-amino-2-(1h)-quinoleinona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2064156T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113977A FR2683818B1 (fr) 1991-11-14 1991-11-14 Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ES2064156T3 true ES2064156T3 (es) 1995-01-16

Family

ID=9418879

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92403014T Expired - Lifetime ES2064156T3 (es) 1991-11-14 1992-11-09 Derivados de 3-sulfonil-amino-2-(1h)-quinoleinona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Country Status (11)

Country Link
EP (1) EP0542609B1 (es)
JP (1) JPH06102650B2 (es)
AT (1) ATE111082T1 (es)
AU (1) AU651255B2 (es)
CA (1) CA2082856A1 (es)
DE (1) DE69200394T2 (es)
DK (1) DK0542609T3 (es)
ES (1) ES2064156T3 (es)
FR (1) FR2683818B1 (es)
NZ (1) NZ245127A (es)
ZA (1) ZA928727B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2709489B1 (fr) * 1993-08-31 1995-10-20 Adir Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2750988B1 (fr) * 1996-07-11 1998-09-18 Adir Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20020065296A1 (en) 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
EP1690853B1 (en) 1999-01-13 2010-03-10 Bayer HealthCare LLC Use of omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
TR200200507T2 (tr) * 1999-08-27 2002-10-21 Ligand Pharmaceuticals Inc Androjen reseptörü modülatör bileşikleri ve metotları
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU7586600A (en) 1999-09-14 2001-04-17 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
FR2805260A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805262A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI298068B (en) * 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
MXPA06001751A (es) 2003-08-22 2006-05-12 Ligand Pharm Inc Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno.
CA2627875A1 (en) 2005-10-31 2007-05-10 Bayer Pharmaceuticals Corporation Combinations comprising sorafenib and interferon for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066145A (en) * 1962-02-07 1962-11-27 American Home Prod 3-amino-6-chloro-4-phenyl-2(1h)-quinolone
EP0386839B1 (en) * 1989-03-08 1997-01-15 Merck Sharp & Dohme Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
GB9004288D0 (en) * 1990-02-26 1990-04-18 Almirall Lab New 4(1h)quinoline derivatives

Also Published As

Publication number Publication date
AU651255B2 (en) 1994-07-14
EP0542609B1 (fr) 1994-09-07
EP0542609A1 (fr) 1993-05-19
JPH06102650B2 (ja) 1994-12-14
ZA928727B (en) 1993-05-10
DE69200394T2 (de) 1995-04-27
ATE111082T1 (de) 1994-09-15
DE69200394D1 (de) 1994-10-13
CA2082856A1 (fr) 1993-05-15
DK0542609T3 (da) 1995-03-20
JPH05221997A (ja) 1993-08-31
NZ245127A (en) 1994-07-26
AU2835192A (en) 1993-05-20
FR2683818B1 (fr) 1993-12-31
FR2683818A1 (fr) 1993-05-21

Similar Documents

Publication Publication Date Title
ES2064156T3 (es) Derivados de 3-sulfonil-amino-2-(1h)-quinoleinona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NL300034I2 (nl) Gesubstitueerde thiahzolidinedionderivaten.
AR005357A1 (es) Derivados de 14-o-carbamoil mutilina y sus sales utiles en el tratamiento de infecciones bacterianas, procedimiento para prepararlas, composicionesfarmaceuticas formuladas con dichos derivados y uso de los mismos para preparar dichas composiciones
MX9203122A (es) Compuestos analogos de distamicina a y composiciones farmaceuticas que los contienen.
DK1484059T3 (da) Antivirale sammensætninger, der omfatter phenyleddikesyre derivater
MX9204622A (es) Nuevos derivados de 3,5-di-tert-butil-4-hidroxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
SE7601207L (sv) Acetylenderivat av acetyleniska aminosyror
ES2020508B3 (es) Derivados citoprotectores utiles para enfermedades isquemicas, su preparacion y composiciones que los contienen.
ES2064941T3 (es) Nuevas acil-benzoxazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
CO4650030A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, proceso para su preparacion y producto farmaceutico que los contiene
FR2709489B1 (fr) Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
MX19565A (es) Nuevos derivados de 1-arilsulfonil-2-piperidinona y procedimiento para su preparacion
FI853866A0 (fi) 2-pyridin-tiol-derivat, foerfarande foer framstaellning av dessa samt farmaceutiska foereningar innehaollande dessa.
ES2063157T3 (es) Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT90815A (pt) Processo de preparacao de derivados da fenotiazina
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
PT95600A (pt) Processo para a preparacao de novos derivados substituidos na posicao 15 da 20,21-dinoreburnamenina e de composicoes farmaceuticas que os contem
SE9002445D0 (sv) Nytt cyklobutanderivat och foerfarande foer framstaellning av detsamma

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 542609

Country of ref document: ES